JP2022526408A5 - - Google Patents
Info
- Publication number
- JP2022526408A5 JP2022526408A5 JP2021559096A JP2021559096A JP2022526408A5 JP 2022526408 A5 JP2022526408 A5 JP 2022526408A5 JP 2021559096 A JP2021559096 A JP 2021559096A JP 2021559096 A JP2021559096 A JP 2021559096A JP 2022526408 A5 JP2022526408 A5 JP 2022526408A5
- Authority
- JP
- Japan
- Prior art keywords
- day
- combination according
- cells
- receptor agonist
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025050426A JP2025089477A (ja) | 2019-04-05 | 2025-03-25 | 細胞免疫療法を増強するための方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962830212P | 2019-04-05 | 2019-04-05 | |
| US62/830,212 | 2019-04-05 | ||
| US201962861858P | 2019-06-14 | 2019-06-14 | |
| US62/861,858 | 2019-06-14 | ||
| US201962898473P | 2019-09-10 | 2019-09-10 | |
| US62/898,473 | 2019-09-10 | ||
| US201962944955P | 2019-12-06 | 2019-12-06 | |
| US62/944,955 | 2019-12-06 | ||
| PCT/US2020/026778 WO2020206395A1 (en) | 2019-04-05 | 2020-04-04 | Method for enhancing cellular immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025050426A Division JP2025089477A (ja) | 2019-04-05 | 2025-03-25 | 細胞免疫療法を増強するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022526408A JP2022526408A (ja) | 2022-05-24 |
| JP2022526408A5 true JP2022526408A5 (enExample) | 2023-04-06 |
| JP7672342B2 JP7672342B2 (ja) | 2025-05-07 |
Family
ID=72666293
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021559096A Active JP7672342B2 (ja) | 2019-04-05 | 2020-04-04 | 細胞免疫療法を増強するための方法 |
| JP2025050426A Pending JP2025089477A (ja) | 2019-04-05 | 2025-03-25 | 細胞免疫療法を増強するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025050426A Pending JP2025089477A (ja) | 2019-04-05 | 2025-03-25 | 細胞免疫療法を増強するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230158164A1 (enExample) |
| EP (1) | EP3946426A4 (enExample) |
| JP (2) | JP7672342B2 (enExample) |
| KR (1) | KR20210149090A (enExample) |
| CN (1) | CN113677362A (enExample) |
| AU (1) | AU2020252569B2 (enExample) |
| CA (1) | CA3134539A1 (enExample) |
| IL (1) | IL286971A (enExample) |
| MX (1) | MX2021012236A (enExample) |
| WO (1) | WO2020206395A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4463135A2 (en) | 2022-01-10 | 2024-11-20 | Sana Biotechnology, Inc. | Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses |
| WO2023193015A1 (en) | 2022-04-01 | 2023-10-05 | Sana Biotechnology, Inc. | Cytokine receptor agonist and viral vector combination therapies |
| WO2024215987A1 (en) * | 2023-04-14 | 2024-10-17 | Sotio Biotech Inc. | IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES |
| EP4694916A1 (en) * | 2023-04-14 | 2026-02-18 | SOTIO Biotech Inc. | Engineered immune cells for treating cancer in combination with il-2/il-15 receptor ?? agonists |
| WO2025191133A1 (en) | 2024-03-15 | 2025-09-18 | Avidicure Ip B.V. | Il-21 muteins, fusion proteins comprising the same and uses thereof |
| WO2025191136A1 (en) | 2024-03-15 | 2025-09-18 | Avidicure Ip B.V. | Muteins of 4-1bb ligand extracellular domain, fusion proteins comprising the same and uses thereof |
| WO2025264864A1 (en) * | 2024-06-18 | 2025-12-26 | Fred Hutchinson Cancer Center | Human anti-cd45 antibodies and uses thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3568474A1 (en) | 2017-01-10 | 2019-11-20 | Intrexon Corporation | Modulating expression of polypeptides via new gene switch expression systems |
| CN108728459B (zh) | 2017-04-24 | 2023-08-04 | 上海恒润达生生物科技股份有限公司 | 靶向cd19的嵌合抗原受体并联合表达il-15的方法和用途 |
| IL270634B2 (en) * | 2017-05-15 | 2025-06-01 | Nektar Therapeutics | Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods |
| US12350312B2 (en) * | 2017-09-06 | 2025-07-08 | Fred Hutchinson Cancer Center | Methods for improving adoptive cell therapy |
-
2020
- 2020-04-04 EP EP20782166.1A patent/EP3946426A4/en active Pending
- 2020-04-04 AU AU2020252569A patent/AU2020252569B2/en active Active
- 2020-04-04 JP JP2021559096A patent/JP7672342B2/ja active Active
- 2020-04-04 US US17/601,611 patent/US20230158164A1/en active Pending
- 2020-04-04 KR KR1020217034537A patent/KR20210149090A/ko active Pending
- 2020-04-04 CN CN202080026218.8A patent/CN113677362A/zh active Pending
- 2020-04-04 WO PCT/US2020/026778 patent/WO2020206395A1/en not_active Ceased
- 2020-04-04 MX MX2021012236A patent/MX2021012236A/es unknown
- 2020-04-04 CA CA3134539A patent/CA3134539A1/en active Pending
-
2021
- 2021-10-04 IL IL286971A patent/IL286971A/en unknown
-
2025
- 2025-03-25 JP JP2025050426A patent/JP2025089477A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022526408A5 (enExample) | ||
| EP3125866B1 (en) | Refillable drug delivery devices and methods of use thereof | |
| CN106132438B (zh) | 与抗CTLA-4抗体或抗PD-1抗体组合的IL-2Rβ选择性激动剂 | |
| JP7770929B2 (ja) | Ｃａｒ－ｔ細胞のインサイチュ動員、リプログラミングおよび放出 | |
| JP7470988B2 (ja) | 生物応答性ヒドロゲルマトリックス及び使用方法 | |
| JP2016533344A5 (enExample) | ||
| JP2010515748A5 (enExample) | ||
| JP2021534101A5 (enExample) | ||
| US20230313191A1 (en) | Rna comprising secretomes and methods of their use | |
| JP2019530673A (ja) | 治療剤送達のための血小板組成物及び方法 | |
| CN112135639B (zh) | 细胞组装介导的癌症免疫治疗检查点抑制剂的递送 | |
| JP2023531122A (ja) | 材料足場を使用した哺乳類細胞の増強されたウイルス形質導入 | |
| CN113197860A (zh) | 聚合物囊泡纳米sting激动剂及其制备方法与应用 | |
| Si et al. | Safety evaluation of biopolymer immune implants in rats and rabbits as well as therapeutic effects on gastric cancer peritoneal metastasis carcinoma | |
| US20250163418A1 (en) | Brush polymer-oligonucleotide conjugates for the treatment of muscular dystrophy | |
| JP7579570B2 (ja) | 術後治療用ｉｎ ｓｉｔｕ噴霧生体応答性免疫療法ゲル | |
| WO2021051066A1 (en) | Her3 pulsed dc1 therapy | |
| US20260124135A1 (en) | Implantable scaffolds and methods of use | |
| WO2020160409A1 (en) | Methods of treating cancer using a combination of tumor membrane vesicles and metformin | |
| US20230257463A1 (en) | In situ thiol-maleimide crosslinked hydrogel for immune checkpoint blockade delivery | |
| WO2025160242A1 (en) | Method of generating tils from cerebro spinal fluid for leptomeningeal disease | |
| HK40121706A (zh) | Car-t细胞的原位募集、重编程与释放 | |
| JP2025535807A (ja) | 移植可能な足場材料及び使用方法 | |
| CN118541164A (zh) | 核酸组合物及其用途 |